应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01093 石药集团
已收盘 04-19 16:08:35
5.770
-0.090
-1.54%
最高
5.820
最低
5.650
成交量
6,034万
今开
5.790
昨收
5.860
日振幅
2.90%
总市值
686.82亿
流通市值
686.82亿
总股本
119.03亿
成交额
3.46亿
换手率
0.51%
流通股本
119.03亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
广发基金刘杰旗下广发中证香港创新药ETF(QDII)一季报最新持仓,重仓石药集团
证券之星 · 06:16
广发基金刘杰旗下广发中证香港创新药ETF(QDII)一季报最新持仓,重仓石药集团
石药集团04月18日主力资金流出338万元 连续3日减仓
自选股智能写手 · 04-18 16:15
石药集团04月18日主力资金流出338万元 连续3日减仓
石药集团(01093.HK)4月17日耗资3492.9万港元回购600万股
格隆汇资讯 · 04-17 18:27
石药集团(01093.HK)4月17日耗资3492.9万港元回购600万股
石药集团(01093)4月17日斥资3492.92万港元回购600万股
智通财经网 · 04-17 18:24
石药集团(01093)4月17日斥资3492.92万港元回购600万股
石药集团(01093)4月16日斥资2908.22万港元回购500万股
智通财经 · 04-16 18:00
石药集团(01093)4月16日斥资2908.22万港元回购500万股
石药集团(01093):合共1950万股新股份于4月15日配发予管理层获授人
智通财经 · 04-15
石药集团(01093):合共1950万股新股份于4月15日配发予管理层获授人
石药集团(01093.HK):根据购股权计划行使购股权
格隆汇资讯 · 04-15
石药集团(01093.HK):根据购股权计划行使购股权
石药集团(01093)出现大手买入94.8万股,成交价$5.88,涉资557.424万
阿斯达克财经 · 04-15
石药集团(01093)出现大手买入94.8万股,成交价$5.88,涉资557.424万
石药集团04月11日收跌1.61% 主力资金逆市抢筹
自选股智能写手 · 04-11
石药集团04月11日收跌1.61% 主力资金逆市抢筹
石药集团(01093)集采影响充分消化,明星产品保持潜力,创新转型将步入密集收获期(繁体版)
第一上海 · 04-11
石药集团(01093)集采影响充分消化,明星产品保持潜力,创新转型将步入密集收获期(繁体版)
石药集团04月08日遭主力抛售503万元 环比增加2858.82%
自选股智能写手 · 04-08
石药集团04月08日遭主力抛售503万元 环比增加2858.82%
石药集团欧意药业有限公司药品申请临床试验默示许可获受理
金融界 · 04-08
石药集团欧意药业有限公司药品申请临床试验默示许可获受理
石药集团(01093)出现大手成交150万股,成交价$6.225,涉资933.75万
阿斯达克财经 · 04-03
石药集团(01093)出现大手成交150万股,成交价$6.225,涉资933.75万
上海证券:全新机制口服降压药获FDA批准上市 关注心血管药物赛道
智通财经 · 04-01
上海证券:全新机制口服降压药获FDA批准上市 关注心血管药物赛道
石药集团03月27日遭主力抛售2638万元 环比增加614.91%
自选股智能写手 · 03-27
石药集团03月27日遭主力抛售2638万元 环比增加614.91%
减肥药市场激战正酣,石药集团、众生药业竞速GLP-1药物研发
观察者网 · 03-27
减肥药市场激战正酣,石药集团、众生药业竞速GLP-1药物研发
石药集团“司美格鲁肽”获批减重临床
华尔街见闻 · 03-26
石药集团“司美格鲁肽”获批减重临床
《大行报告》汇丰研究降石药(01093.HK)目标价至7元 创新项目步入正轨
阿斯达克财经 · 03-26
《大行报告》汇丰研究降石药(01093.HK)目标价至7元 创新项目步入正轨
南向资金3月25日净卖出石药集团775.40万股 连续3日减持
自选股智能写手 · 03-26
南向资金3月25日净卖出石药集团775.40万股 连续3日减持
国产“减肥神药”竞速:石药集团司美格鲁肽获批临床,众生药业公布双靶点药物数据
澎湃新闻 · 03-26
国产“减肥神药”竞速:石药集团司美格鲁肽获批临床,众生药业公布双靶点药物数据
暂无数据
公司概况
公司名称:
石药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石药集团有限公司是一家主要从事药品生产和销售的投资控股公司。该公司以“石药”品牌销售其产品。该公司包括四个业务部门:成药部门、抗生素(中间体及原料药)部门、维生素C(原料药)部门及咖啡因及其他(原料药)部门,分别从事生产及销售相关药品业务。该公司的成药包括抗生素、心脑血管用药、糖尿病用药、精神神经用药、抗肿瘤用药及中医药产品。该公司还通过其子公司从事提供药品研发服务及污水及药物副产品处理业务。
发行价格:
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":5.77,"timestamp":1713514115029,"preClose":5.86,"halted":0,"volume":60339858,"delay":0,"floatShares":11903219732,"shares":11903219732,"eps":0.5342257,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.09,"latestTime":"04-19 16:08:35","open":5.79,"high":5.82,"low":5.65,"amount":346371307,"amplitude":0.02901,"askPrice":5.79,"askSize":408000,"bidPrice":5.77,"bidSize":770000,"shortable":3,"etf":0,"ttmEps":0.5342051796915993,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":772128000000,"adjPreClose":5.86,"dividendRate":0.047586,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.481926,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":true,"expireDate":1716998400000,"strike":"6.75","timestamp":1713508668488,"price":0.03999999910593033,"volume":400,"amount":32000,"type":"*"},{"symbol":"CSP.HK","call":false,"expireDate":1716998400000,"strike":"5.25","timestamp":1713508549614,"price":0.07000000029802322,"volume":299,"amount":41860,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK"},"requestUrl":"/m/hq/s/01093/tweets","defaultTab":"tweets","newsList":[{"id":"2428526866","title":"广发基金刘杰旗下广发中证香港创新药ETF(QDII)一季报最新持仓,重仓石药集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2428526866","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428526866?lang=zh_cn&edition=full","pubTime":"2024-04-19 06:16","pubTimestamp":1713478598,"startTime":"0","endTime":"0","summary":"证券之星消息,4月19日广发基金旗下刘杰管理的广发中证香港创新药交易型开放式指数基金(QDII)公布一季报,近1年净值增长率-40.51%。与上一季度相比,该基金前十大重仓股新增翰森制药,和黄医药;并对石药集团增仓779.4万股,为该基金第一大重仓股;再鼎医药,康哲药业等退出前十大重仓股;详细数据如下:以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190618198b37adc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190618198b37adc6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428551285","title":"石药集团04月18日主力资金流出338万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428551285","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428551285?lang=zh_cn&edition=full","pubTime":"2024-04-18 16:15","pubTimestamp":1713428138,"startTime":"0","endTime":"0","summary":"04月18日, 石药集团股价涨0.86%,报收5.86元,成交金额2.77亿元,换手率0.40%,振幅3.10%,量比1.23。石药集团今日主力资金净流出338万元,连续3日净流出,上一交易日主力净流出1753万元,今日环比减少80.72%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为33.33%,平均跌幅为1.42%。该股近5个交易日下跌4.58%,主力资金累计净流出3923万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出4726万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181615598b34bcfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181615598b34bcfe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428631892","title":"石药集团(01093.HK)4月17日耗资3492.9万港元回购600万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428631892","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428631892?lang=zh_cn&edition=full","pubTime":"2024-04-17 18:27","pubTimestamp":1713349647,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨石药集团(01093.HK)公告,4月17日耗资3492.9万港元回购600万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171827328788875d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171827328788875d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428731888","title":"石药集团(01093)4月17日斥资3492.92万港元回购600万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428731888","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2428731888?lang=zh_cn&edition=full","pubTime":"2024-04-17 18:24","pubTimestamp":1713349441,"startTime":"0","endTime":"0","summary":"石药集团(01093)发布公告,于2024年4月17日,该公司斥资3492.92万...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_46.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_46.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103966.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427849681","title":"石药集团(01093)4月16日斥资2908.22万港元回购500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427849681","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427849681?lang=zh_cn&edition=full","pubTime":"2024-04-16 18:00","pubTimestamp":1713261636,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)发布公告,于2024年4月16日,该公司斥资2908.22万港元回购500万股,每股回购价为5.77-5.85港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103364.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427024131","title":"石药集团(01093):合共1950万股新股份于4月15日配发予管理层获授人","url":"https://stock-news.laohu8.com/highlight/detail?id=2427024131","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427024131?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:24","pubTimestamp":1713173081,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)发布公告,于本公告日期,第一批购股权的归属条件已告达成。于2024年4月11日,合共1950万份购股权(属第一批购股权的一部分)已由下列若干管理层获授人行使,行使价为每股5.98港元。于行使第一批购股权后,合共1950万股新股份已于2024年4月15日配发及发行予上述管理层获授人。因此,紧随发行后,公司已发行股份总数为119.23亿股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102568.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427524024","title":"石药集团(01093.HK):根据购股权计划行使购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2427524024","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427524024?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:24","pubTimestamp":1713173041,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨石药集团(01093.HK)发布公告,于本公告日期,第一批购股权的归属条件已告达成。2024年4月11日,合共1950万份购股权(属第一批购股权的一部分)已由若干管理层获授人行使,行使价为每股5.98港元(“行使第一批购股权”)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151724048b256c5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151724048b256c5b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427395019","title":"石药集团(01093)出现大手买入94.8万股,成交价$5.88,涉资557.424万","url":"https://stock-news.laohu8.com/highlight/detail?id=2427395019","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427395019?lang=zh_cn&edition=full","pubTime":"2024-04-15 11:05","pubTimestamp":1713150300,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在上午11:05出现大手买入,成交量为94.8万,成交价为港币$5.88,涉资557.424万。至目前为止,股价跌1.178%,今日最高价为$5.92,而最低价为$5.81,总成交量为1.57千万股,总成交金额港币$9.207千万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404152164/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426238991","title":"石药集团04月11日收跌1.61% 主力资金逆市抢筹","url":"https://stock-news.laohu8.com/highlight/detail?id=2426238991","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426238991?lang=zh_cn&edition=full","pubTime":"2024-04-11 16:16","pubTimestamp":1712823416,"startTime":"0","endTime":"0","summary":"04月11日, 石药集团股价跌1.61%,报收6.12元,成交金额2.14亿元,换手率0.29%,振幅1.61%,量比1.28。石药集团今日主力资金净流入3905万元,连续3日净流入,上一交易日主力净流入611万元,今日环比增加539.12%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为35.29%,平均涨幅为1.95%。该股近5个交易日下跌1.29%,主力资金累计净流入6944万元;近20日主力资金累计净流出3917万元,其中净流出天数为12日。该股主力净额占比0.05%,港股市场排名97/2628。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041116171887667ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041116171887667ad4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426404399","title":"石药集团(01093)集采影响充分消化,明星产品保持潜力,创新转型将步入密集收获期(繁体版)","url":"https://stock-news.laohu8.com/highlight/detail?id=2426404399","media":"第一上海","top":-1,"share":"https://www.laohu8.com/m/news/2426404399?lang=zh_cn&edition=full","pubTime":"2024-04-11 12:16","pubTimestamp":1712808995,"startTime":"0","endTime":"0","summary":"恩必普双向拓展维持潜力,新产品陆续上市接力增长:2023年公司神经系统领域收入90.89亿元,占成药收入比例扩大至35.4%。作为刚需型用药,恩必普仍然保持增长趋势。丁苯酞注射剂型和软胶囊专利到期后,公司仍然握有一项丁苯酞药物活性组合物及其制备方法的专利,2032年到期。此外,公司也正在积极开发新适应症,以进一步延长恩必普的生命周期。借助国家大力扶持创新药的东风,公司创新转型战略将进一步取得成效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111230278b0e2a6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111230278b0e2a6d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425951663","title":"石药集团04月08日遭主力抛售503万元 环比增加2858.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425951663","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425951663?lang=zh_cn&edition=full","pubTime":"2024-04-08 16:16","pubTimestamp":1712564217,"startTime":"0","endTime":"0","summary":"04月08日,石药集团股价收平报6.15元,成交金额1.55亿元,换手率0.21%,振幅2.93%,量比0.66。石药集团今日主力资金净流出503万元,上一交易日主力净流出17万元,今日环比增加2858.82%。该股近5个交易日下跌1.75%,主力资金累计净流出682万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1.26亿元,其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081617188afdc9d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081617188afdc9d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425670938","title":"石药集团欧意药业有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2425670938","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425670938?lang=zh_cn&edition=full","pubTime":"2024-04-08 13:11","pubTimestamp":1712553105,"startTime":"0","endTime":"0","summary":"4月8日,据CDE官网消息,石药集团欧意药业有限公司联合申请药品“普瑞巴林缓释片”,获得临床试验默示许可,受理号CYHL2400019。公示信息显示,药品“普瑞巴林缓释片”适应症:与糖尿病周围神经病变相关的神经性疼痛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081311498afd3680&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081311498afd3680&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424286642","title":"石药集团(01093)出现大手成交150万股,成交价$6.225,涉资933.75万","url":"https://stock-news.laohu8.com/highlight/detail?id=2424286642","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424286642?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:05","pubTimestamp":1712127900,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在下午03:05出现大手成交,成交量为150万,成交价为港币$6.225,涉资933.75万。至目前为止,股价跌2.044%,今日最高价为$6.37,而最低价为$6.18,总成交量为2.369千万股,总成交金额港币$1.478亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404032834/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424365357","title":"上海证券:全新机制口服降压药获FDA批准上市 关注心血管药物赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2424365357","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424365357?lang=zh_cn&edition=full","pubTime":"2024-04-01 10:23","pubTimestamp":1711938227,"startTime":"0","endTime":"0","summary":"上海证券主要观点如下:全新机制口服降压药Tryvio获批2024年3月19日,美国FDA宣布批准Idorsia研发的新分子实体药物Tryvio上市。诺和诺德扩充心血管药物管线,PCSK9势头强劲近日,诺和诺德宣布,将以10.3亿欧元的价格收购Cardior Pharmaceuticals,以期进一步扩充心血管药物管线。2023年8月有两款PCSK9抑制剂新药获批上市,分别是信达生物自主研发的托莱西单抗,和诺华的英克司兰钠注射液。目前,恒瑞医药、君实生物的PCSK9单抗均已申请上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1096796.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422959106","title":"石药集团03月27日遭主力抛售2638万元 环比增加614.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422959106","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422959106?lang=zh_cn&edition=full","pubTime":"2024-03-27 16:16","pubTimestamp":1711527361,"startTime":"0","endTime":"0","summary":"03月27日, 石药集团股价跌1.26%,报收6.27元,成交金额4.01亿元,换手率0.53%,振幅2.20%,量比1.29。石药集团今日主力资金净流出2638万元,连续5日净流出,上一交易日主力净流出369万元,今日环比增加614.91%。该股近5个交易日下跌1.56%,主力资金累计净流出8532万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1.49亿元,其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271616218b68e3cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271616218b68e3cd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422983051","title":"减肥药市场激战正酣,石药集团、众生药业竞速GLP-1药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2422983051","media":"观察者网","top":-1,"share":"https://www.laohu8.com/m/news/2422983051?lang=zh_cn&edition=full","pubTime":"2024-03-27 10:59","pubTimestamp":1711508383,"startTime":"0","endTime":"0","summary":"这一研究成果不仅为石药集团赢得了市场先机,也进一步证明了GLP-1药物在减重领域的巨大潜力。此外,石药集团还在研发另一款GLP-1药物TG103注射液。这一成果为众生药业在GLP-1药物市场的布局增添了重要筹码。随着全球糖尿病药物市场的不断扩大,GLP-1药物成为了各大药企竞相追逐的热点。随着国内药企不断推进GLP-1药物临床试验,未来市场竞争或将愈发激烈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032711003487ba4ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032711003487ba4ad4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422669881","title":"石药集团“司美格鲁肽”获批减重临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2422669881","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2422669881?lang=zh_cn&edition=full","pubTime":"2024-03-26 17:23","pubTimestamp":1711444995,"startTime":"0","endTime":"0","summary":"临床前研究结果显示,该产品与 DNA 重组技术制备的司美格鲁肽注射液具有相似的生物活性和减重效果;在食蟹猴体内具有一致的代谢特征和安全性,无全身主动过敏反应且局部耐受性良好。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/2c9f1634-d278-4e3d-84d0-cddc6976ecd2","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/2c9f1634-d278-4e3d-84d0-cddc6976ecd2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3711337","is_publish_highlight":false,"gpt_icon":0},{"id":"2422682604","title":"《大行报告》汇丰研究降石药(01093.HK)目标价至7元 创新项目步入正轨","url":"https://stock-news.laohu8.com/highlight/detail?id=2422682604","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422682604?lang=zh_cn&edition=full","pubTime":"2024-03-26 10:33","pubTimestamp":1711420380,"startTime":"0","endTime":"0","summary":"汇丰环球研究发表报告指,石药去年收入增长1.7%,但纯利下跌3.6%,差过该行预期。展望今年,预期新药推出将会抵销部分产品价格下跌的影响,其快速提升的平台将会支持未来业务研发及长远增长,不过带量采购可能对其主要产品有潜在负面影响。该行指,石药股价年初至今下跌12%,主要因为市场对带量采购的忧虑影响,现价相当于今年预测市盈率11倍,属合理估值,维持其“持有”评级,目标价由7.25元下调至7元。沽空资料截至 2024-03-25 16:25。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230531121547900_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230531121547900_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336974/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422838286","title":"南向资金3月25日净卖出石药集团775.40万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2422838286","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422838286?lang=zh_cn&edition=full","pubTime":"2024-03-26 09:31","pubTimestamp":1711416674,"startTime":"0","endTime":"0","summary":"3月25日,南向资金减持石药集团775.40万股连续3日减持。截止当日收盘,港股通共持有石药集团151949.10万股,占流通股12.75%。港股通减持金额前五个股分别为中国海洋石油、汇丰控股、泡泡玛特、吉利汽车、中芯国际。石药集团近5个交易日下跌3.06%,港股通累计减持2150.97万股;近20个交易日上涨0.79%,港股通累计减持3512.66万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260945568b634076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260945568b634076&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422795508","title":"国产“减肥神药”竞速:石药集团司美格鲁肽获批临床,众生药业公布双靶点药物数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2422795508","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2422795508?lang=zh_cn&edition=full","pubTime":"2024-03-26 07:04","pubTimestamp":1711407840,"startTime":"0","endTime":"0","summary":"国产“减肥神药”迎来新成员2023年8月,石药集团曾公告称,其司美格鲁肽注射液获批临床用于成人二型糖尿病治疗。石药集团并非首个推动司美格鲁肽注射液的国内药企。今年2月,丽珠集团、翰宇药业等多家药企公告称,司美格鲁肽减重适应证获批临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032607045587b4d77d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032607045587b4d77d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.0425},{"period":"1month","weight":-0.0872},{"period":"3month","weight":-0.0085},{"period":"6month","weight":0.0502},{"period":"1year","weight":-0.2391},{"period":"ytd","weight":-0.1928}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事药品生产和销售的投资控股公司。该公司以“石药”品牌销售其产品。该公司包括四个业务部门:成药部门、抗生素(中间体及原料药)部门、维生素C(原料药)部门及咖啡因及其他(原料药)部门,分别从事生产及销售相关药品业务。该公司的成药包括抗生素、心脑血管用药、糖尿病用药、精神神经用药、抗肿瘤用药及中医药产品。该公司还通过其子公司从事提供药品研发服务及污水及药物副产品处理业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.007621},{"month":2,"riseRate":0.733333,"avgChangeRate":0.097752},{"month":3,"riseRate":0.466667,"avgChangeRate":0.01981},{"month":4,"riseRate":0.566667,"avgChangeRate":0.052922},{"month":5,"riseRate":0.586207,"avgChangeRate":0.038691},{"month":6,"riseRate":0.344828,"avgChangeRate":0.00713},{"month":7,"riseRate":0.366667,"avgChangeRate":0.002269},{"month":8,"riseRate":0.433333,"avgChangeRate":0.015994},{"month":9,"riseRate":0.5,"avgChangeRate":-0.005631},{"month":10,"riseRate":0.6,"avgChangeRate":0.0171},{"month":11,"riseRate":0.466667,"avgChangeRate":0.009686},{"month":12,"riseRate":0.5,"avgChangeRate":-0.014286}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}